Skip Navigation


JAC Advance Access originally published online on July 5, 2007
Journal of Antimicrobial Chemotherapy 2007 60(3):655-657; doi:10.1093/jac/dkm252
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow All Versions of this Article:
60/3/655    most recent
dkm252v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (1)
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Aragón, L. M.
Right arrow Articles by Coll, P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Aragón, L. M.
Right arrow Articles by Coll, P.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© The Author 2007. Published by Oxford University Press on behalf of the British Society for Antimicrobial Chemotherapy. All rights reserved. For Permissions, please e-mail: journals.permissions@oxfordjournals.org

Evaluation of the BacT/ALERT PZA kit in comparison with the BACTEC 460TB PZA for testing Mycobacterium tuberculosis susceptibility to pyrazinamide

Lina Marcela Aragón1, Montserrat Garrigó1,2, Carmen Moreno1, Montserrat Español1 and Pere Coll1,2,*

1 Servei de Microbiología, Hospital de la Santa Creu i Sant Pau, Av. Sant Antoni Ma Claret, 167, 08025 Barcelona, Spain 2 Departament de Genètica i Microbiologia, Universitat Autònoma de Barcelona, 08193 Cerdanyola del Vallès, Spain

Received 3 May 2007; returned 6 June 2007; revised 13 June 2007; accepted 15 June 2007

* Corresponding author. Tel: +34-93-2919069; Fax: +34-93-2919070; E-mail: pcoll{at}santpau.es

Objectives: To compare the performance of the BacT/ALERT PZA kit (BioMerieux, Marcy l'Etoile, France) with the radiometric BACTEC 460TB PZA test (Becton–Dickinson method) for testing Mycobacterium tuberculosis susceptibility to pyrazinamide.

Methods: A total of 50 M. tuberculosis strains were tested. Thirty of these strains had been previously considered pyrazinamide-susceptible and 20 pyrazinamide-resistant by BACTEC 460TB.

Results: Final overall agreement was 100%. Time needed for the susceptibility test was 6.69 days for the BacT/ALERT PZA kit versus 8.07 days for the BACTEC 460TB PZA test.

Conclusions: BacT/ALERT PZA test is an excellent alternative to BACTEC 460TB for pyrazinamide susceptibility testing.

Keywords: susceptibility testing , resistance , tuberculosis


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 Antimicrob. Agents Chemother.Home page
P. Jureen, J. Werngren, J.-C. Toro, and S. Hoffner
Pyrazinamide Resistance and pncA Gene Mutations in Mycobacterium tuberculosis
Antimicrob. Agents Chemother., May 1, 2008; 52(5): 1852 - 1854.
[Abstract] [Full Text] [PDF]


Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.